On Friday, the Food and Drug Administration (FDA) issued a letter advising doctors, clinics and others promoting LASIK eye surgery that their advertisements must tell consumers about possible risks, and that commercials and other promotions that do not convey necessary warnings concerning side-effects and other precautions are deceptive.

The letter comes more than a year after the FDA held a public meeting that drew dozens of unhappy patients who complained of blurriness, double-vision, depression and other problems after undergoing LASIK.

Read ^[1] the full press release.